Results 91 to 100 of about 2,912,203 (303)
British Journal of Clinical Pharmacology, Volume 91, Issue 7, Page 2070-2079, July 2025.Abstract Aims Paltusotine is a novel, nonpeptide, selective somatostatin receptor 2 agonist in development for the treatment of acromegaly and carcinoid syndrome. This study investigated the mass balance, routes of excretion, absolute bioavailability and metabolite profile of orally administered paltusotine.
Rosa Luo +6 more
wiley +1 more source
An Unusual Case of Synchronous Carcinoid of Ovary and Gall Bladder [PDF]
, 2013 Multifocal carcinoid is a known phenomenon. We present a rare combination of an ovarian carcinoid synchronous with gallbladder carcinoid. This rare combination has not been reported so far.
Nita Khurana +3 more
core +2 more sources
Carcinoid Syndrome-Induced Ventricular Tachycardia
Case Reports in Cardiology, 2016 Introduction. Carcinoid tumors are rare neuroendocrine malignancies that secrete multiple bioactive substances. These bioactive substances are responsible for the carcinoid syndrome characterized by diarrhea, flushing, syncope, and right-sided valvular ...
Austin B. Rupp +3 more
doaj +1 more source
Rare Tumors, 2010 Monodermal teratomas of the ovary can take the form of carcinoid tumors of which there are several types, mucinous carcinoid being the least common. Very few cases of primary mucinous carcinoid of the ovary have been reported in the literature and the ...
Patricia C. Ewing +3 more
doaj +1 more source
Reimbursement of Lung Cancer in Turkey: A 10‐Year Single Center Study
Cancer Medicine, Volume 14, Issue 13, July 2025.ABSTRACT Objective and Background Lung cancer is the most common carcinoma reported worldwide. The burden of lung carcinoma on healthcare has been reported in many countries, while a real‐life report within Turkey has yet to be published. This study aims to present the available results from a tertiary center specializing in pulmonology.
Kerem Ensarioğlu +3 more
wiley +1 more source
World Journal of Gastroenterology, 2015 AIM To review literature on efficacy and safety of octreotide-long-acting repeatable (LAR) used at doses higher than the Food and Drug Administration (FDA)-approved 30 mg/mo for treatment of neuroendocrine tumors (NETs).
M. Broder +4 more
semanticscholar +1 more source
Cancer Medicine, Volume 14, Issue 14, July 2025.ABSTRACT Background Multimodality therapy incorporating a combination of cytoreductive surgery (CRS), intraperitoneal (IP) and systemic therapy continues to evolve for peritoneal carcinomatosis (PC) However, treatment and outcomes vary depending on tumor of origin.
Expert Panel Management of Peritoneal Carcinomatosis +18 more
wiley +1 more source
Struma Ovarii Associated with Pseudo- Meigs’Syndrome [PDF]
, 2012 Struma ovarii is a specialized ovarian teratoma composed predominantly of mature thyroid tissue. It is associated with pleural effusion and ascites (Pseudo-Meigs’ syndrome) in 5% of cases.
Gangane, NM, Gulhane, SR, Sinha, RT
core +1 more source
World Journal of Surgical Oncology, 2011 Background Midgut carcinoids are neuroendocrine tumors that commonly metastasize to the intestinal mesentery, where they predispose to intestinal obstruction, ischemia and/or congestion.
Cosimi A Benedict +4 more
doaj +1 more source
Mushroom Bioactive Molecules as Anticancerous Agents: An Overview
Food Science &Nutrition, Volume 13, Issue 7, July 2025.This review discusses the molecular mechanisms through which these compounds inhibit cancer progression, including the induction of reactive oxygen species, inhibition of mitotic kinase and angiogenesis, and suppression of topoisomerase activity. By providing the latest insights on these anti‐tumor agents and their pharmacological actions, our review ...
Ali Ikram +10 more
wiley +1 more source